Esomeprazole and omeprazole could boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) leading to elevated adverse effects for example drowsiness, although the scientific relevance is very low in many individuals – observe the client for adverse effects (e.If affected individual can not resume their regular oral medication p